Treatment of Steroid-Resistant Acute Graft-Versus-Host Disease With Daclizumab and Etanercept

Bone Marrow Transplantation- United Kingdom

doi 10.1038/sj.bmt.1704929

Full Text

Abstract

Available in

Date

Authors

Publisher

Springer Science and Business Media LLC

Related search

Etanercept as Treatment of Steroid-Refractory Acute Graft Versus Host Disease in Pediatric Patients

Biology of Blood and Marrow Transplantation
TransplantationHematology
2019English

Sirolimus for Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease

Bone Marrow Transplantation
TransplantationHematology
2009English

Etanercept in Graft-Versus-Host Disease

Bone Marrow Transplantation
TransplantationHematology
2000English

Tocilizumab for Steroid Refractory Acute Graft-Versus-Host Disease

Leukemia and Lymphoma
Cancer ResearchOncologyHematology
2015English

Rapid Response to Alefacept Given to Patients With Steroid Resistant or Steroid Dependent Acute Graft-Versus-Host Disease: A Preliminary Report

Bone Marrow Transplantation
TransplantationHematology
2005English

Outcomes of Infliximab in Management of Steroid-Refractory Acute Graft Versus Host Disease

Biology of Blood and Marrow Transplantation
TransplantationHematology
2019English

Treatment of Severe Therapy-Resistant Acute Graft-Versus-Host Disease With Human Adipose Tissue-Derived Mesenchymal Stem Cells

Bone Marrow Transplantation
TransplantationHematology
2006English

Experience With the Use of Infliximab and/or Extracorporeal Photopheresis in Steroid-Refractory Acute Graft Versus Host Disease

Biology of Blood and Marrow Transplantation
TransplantationHematology
2018English

Updated Experience With Inolimomab as Treatment for Corticosteroid-Refractory Acute Graft-Versus-Host Disease

Biology of Blood and Marrow Transplantation
TransplantationHematology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy